Detalhe da pesquisa
1.
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
BMC Med
; 21(1): 94, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927541
2.
The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study.
BMC Cancer
; 22(1): 505, 2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524225
3.
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study.
Cancer Cell Int
; 21(1): 604, 2021 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34772421
4.
Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer.
J Natl Compr Canc Netw
; 17(10): 1174-1183, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590148
5.
The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor.
J Transl Med
; 16(1): 273, 2018 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30286769
6.
Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients.
J Transl Med
; 16(1): 195, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005666
7.
Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
BMC Cancer
; 17(1): 873, 2017 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29262803
8.
A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients.
Int J Cancer
; 136(3): 584-92, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916890
9.
Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real-world study based on medical comorbidities.
Head Neck
; 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366693
10.
Regorafenib with or without a programmed cell death protein 1 antibody as third-line treatment for microsatellite stable metastatic colorectal cancer.
Cancer Med
; 12(6): 6488-6498, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373163
11.
The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy.
Radiother Oncol
; 178: 109414, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375563
12.
Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study.
J Cancer Res Clin Oncol
; 149(13): 11929-11940, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418058
13.
Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
Eur J Cancer
; 194: 113337, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862797
14.
Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?
J Cancer Res Clin Oncol
; 148(10): 2569-2579, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618220
15.
Development of a web-based prognostic model to quantify the survival benefit of cumulative cisplatin dose during concurrent chemoradiotherapy in childhood nasopharyngeal carcinoma.
Radiother Oncol
; 166: 118-125, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838885
16.
The prognostic value of adding systemic inflammation response index to Epstein-Barr virus DNA in childhood nasopharyngeal carcinoma: A real-world study.
Head Neck
; 44(6): 1404-1413, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373866
17.
Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer.
Cancer Med
; 10(24): 8876-8882, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741450
18.
The effect of adding concurrent chemotherapy to radiotherapy for stage II nasopharyngeal carcinoma with undetectable pretreatment Epstein-Barr virus DNA: Retrospective analysis with a large institutional-based cohort.
Transl Oncol
; 14(2): 100990, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338876
19.
Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study.
Radiother Oncol
; 161: 83-91, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34116076
20.
[Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].
Zhonghua Zhong Liu Za Zhi
; 32(10): 777-81, 2010 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-21163071